Can the Interim Fluorodeoxyglucose-Positron Emission Tomography Standardized Uptake Value Be Used to Determine the Need for Residual Mass Biopsy After Dose-Dense Immunochemotherapy for Advanced Diffuse Large B-Cell Lymphoma?

JOURNAL OF CLINICAL ONCOLOGY

AMER SOC CLINICAL ONCOLOGY

1. NCI NIH HHS [P30 CA086862] Funding Source: Medline